Purpose: The pharmacology, pharmacokinetics, drug interactions, clinical efficacy, adverse effects, monitoring, and dosage and administration of enteric-coated (EC) mycophenolate sodium are reviewed.

The efficacy and toxicity of mycophenolate mofetil (MMF) are concentration-dependent, yet a standard fixed dose of 2 g/day is currently recommended for maintenance immunosuppression in adult renal ...

The data discussed earlier indicate that MMF may have value as an alternative treatment for AIH patients who do not respond to standard treatment. However, more data are required. Randomized ...

Preddie et al. have investigated whether the immunosuppressant mycophenolate mofetil (MMF) could be useful in such patients. The study included eight patients with biopsy-proven AIN who had ...